The long‐acting β2‐adrenoceptor agonist olodaterol attenuates pulmonary inflammation

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 14, 2015-07 ,pp. : 3537-3547

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacodynamics of GR‐mediated gene expression

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 5, 2015-03 ,pp. : 1360-1378

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of chronic treatment with the new ultra‐long‐acting β2‐adrenoceptor agonist indacaterol alone or in combination with the β1‐adrenoceptor blocker metoprolol on cardiac remodelling

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 172, Iss. 14, 2015-07 ,pp. : 3627-3637

John Wiley & Sons Inc

Access to resources Recommend Favorite

Indacaterol, a novel inhaled, once-daily, long-acting beta 2 -agonist for the treatment of obstructive airways diseases

By Beeh Kai  

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 691-699

Springer Publishing Company

Access to resources Recommend Favorite

Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus

By Seino Yutaka   Nakajima Hiromu   Miyahara Hajime   Kurita Takashi   Bush Mark A.   Yang Fred   Stewart Murray W.    

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 3049-3057

Informa Healthcare

Access to resources Recommend Favorite